Key takeaways
Nayzilam (midazolam) and ezogabine (Potiga) are both medications used to treat seizures, but they belong to different medication classes and have distinct characteristics. Nayzilam is a benzodiazepine available as a nasal spray, specifically used for treating seizure attacks in people with epilepsy who are 12 years and older. It is a Schedule IV controlled substance and is only available as a brand-name medication. Common side effects include drowsiness, nasal discomfort, and headache. It can interact with opioids, alcohol, and other sedatives, increasing the risk of severe drowsiness and breathing problems. On the other hand, ezogabine was an antiepileptic medication used for partial-onset seizures in adults. However, ezogabine is no longer available in the United States due to low usage, not safety concerns.
